- $19.79bn
- $20.19bn
- $982.02m
Brief: Guardant Health And Zephyr Ai Announce Partnership To Unlock Drug Response Predictions And Biomarker Insights
Brief: Guardant Health And Collaborators To Present New Data Across The Cancer Care Continuum At Esmo 2025
Brief: FDA Approves Guardant360 CDX As Companion Diagnostic For Eli Lilly
U.S. RESEARCH ROUNDUP- Carmax, Mirion Technologies, Valmont Industries
U.S. RESEARCH ROUNDUP- Apogee Therapeutics, Intel, Northern Trust
Brief: Alex M. Azar Ii Joins Guardant Health Board Of Directors
Brief: Guardant Health Expands Access To Shield CRC Blood Test To Senior Living Communities With Labflorida Partnership
Brief: Guardant Health, PathGroup Partner to Bring Shield Blood Test to 250+ Hospitals Across 25 States
U.S. RESEARCH ROUNDUP-Applovin, GE Vernova, Salesforce
Brief: Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule
Exact Sciences falls after disappointing colorectal cancer test results
Guardant Health Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Guardant Health Q2 Adjusted EPS USD -0.44 Vs. IBES Estimate USD -0.79
US judge rebukes law firm Quinn Emanuel, awards $3 million sanction in Guardant case
U.S. STOCKS ON THE MOVE-Estee Lauder, TC Energy, Cancer test makers
Gilead, cancer test makers up after U.S. top court ruling on preventative coverage
Gilead shares rise after US top court ruling on preventative coverage (updated)
Gilead, cancer test makers up after U.S. top court ruling on preventative coverage
U.S. STOCKS ON THE MOVE-Guardant Health, Hewlett Packard Enterprise, Venture Global